We are incredibly excited to announce the launch of Ring of Support in collaboration with our clinical partner, SE Health. Ring of Support is an intelligent personalized and multi-modal engagement platform using the Amazon Alexa Voice Assistant, home telephones and mobile messaging. Ring Of Support was created to support individuals […]
Introducing Dot the Diabetes Carebot… Advanced analytics and machine learning have the potential to be game changers in the detection and management of diabetes. In the new year, in partnership with the health analytics company, MEMOTEXT and Green Shield Canada (GSC) GSC launch Dot the Diabetes Carebot. Dot is a […]
Posted on March 15, 2016 by Mary Camp Another HIMSS conference makes it three in a row for me. I feel like a veteran and enjoyed sharing my inside tips for rookies: arrive early for your sessions to get a seat, choose comfort over style in footwear, pack snacks and water, be […]
TORONTO, Feb. 4, 2016 /CNW/ – A 2014 pilot program for patients with chronic diseases by Green Shield Canada (GSC) and MEMOTEXT Corp. has revealed some new facts about non-adherence to medication. Compiled into “The Importance of Sticking to it” whitepaper, data from the Stick2It program shows that a […]
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.
Posted on November 05, 2015 by Noah Nemoy
Medication Compliance is one of the biggest costs to worldwide healthcare systems. 50% of all patients do not take their medication as prescribed and this costs the U.S. healthcare system alone $290 billion per year. That’s a pretty massive figure that can be interpreted in several ways.
We can start by breaking down that $290 billion to show exactly how low compliance rates create such a huge cost:
How MEMOTEXT helps you achieve it
Posted on October 13, 2015 by Noah Nemoy
If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?
Attendees can expect to learn about a successful collaborative case study in digital health personalization and adherence engagement
Posted on May 28, 2015 by Noah Nemoy
PerformRx and MEMOTEXT Corp. are pleased to announce their joint presentation on HealthNHandSM at the Consulate General of Canada’s The Digital Transformation of Patient Care: New Avenues for Pharma Growth Seminar in Philadelphia, on June 15th. HealthNHand is being cited as successful case study, in both digital health personalization and adherence engagement.
Posted on March 05, 2015 by Amos Adler
Some of our MEMOTEXT programs personalize interventions based on what’s known as stages of change. Stage of change, or the transtheoretical model, is used to asses and prescribe appropriate information, motivation and guidance to move people towards behavior change. In plain English, are people ready to adopt healthier behaviors?
Posted on March 02, 2015 by Amos Adler
WARNING: This blog post may offend some innovation seekers while inspiring others
I recently had an interaction with an organization supports innovation in knowledge-based industries. Several discussions with a representative of the organization revealed to me something that was a bit more common than I wanted to acknowledge: There are a lot of organizations that support the idea of innovation but have no real framework for it.